v3.26.1
CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Statement of Cash Flows [Abstract]    
Net income $ 166,845 $ 117,571
Adjustments to reconcile net income to net cash provided by operating activities:    
Stock-based compensation expense 58,567 70,394
Depreciation 14,132 21,729
Impairments and amortization of intangibles 33,767 10,478
Deferred income taxes 11,641 (3,722)
Other adjustments, net 2,211 5,325
Changes in assets and liabilities    
Accounts receivable 8,992 2,510
Other assets (9,450) 15,230
Accounts payable and other liabilities (98,042) (49,339)
Income taxes payable and receivable 6,491 11,525
Deferred revenue (796) (8,584)
Net cash provided by operating activities 194,358 193,117
Cash flows from investing activities:    
Capital expenditures (20,384) (15,427)
Other, net 0 (1,067)
Net cash used in investing activities (20,384) (16,494)
Cash flows from financing activities:    
Principal payments on Term Loan 0 (425,000)
Proceeds from issuance of common stock pursuant to stock-based awards and employee stock purchase plan 0 378
Withholding taxes paid on behalf of employees on net settled stock-based awards (74,848) (78,749)
Purchase of treasury stock (60,104) (188,676)
Dividends (44,189) (47,791)
Purchase of noncontrolling interests (232) (84)
Other, net 0 (374)
Net cash used in financing activities (179,373) (740,296)
Total cash used (5,399) (563,673)
Effect of exchange rate changes on cash and cash equivalents (2,344) 7,102
Net decrease in cash and cash equivalents (7,743) (556,571)
Cash and cash equivalents at beginning of period 1,027,838 965,993
Cash and cash equivalents at end of period $ 1,020,095 $ 409,422